18 to 45 Years
The study consists in collecting umbilical cord blood cells from newborns at risk of sickle
cell disease, to perform laboratory experiments aiming to characterize the cells with HbS/HbS
mutation, to develop methods to prepare, to gene-modify and to preserve these cells.
– Pregnant women, giving birth at CHSF and consenting to the collect and study of
placental blood after delivery
– Age 18 to 45 years
– Biological testing of the participant includes hemoglobin electrophoresis and shows at
least one HbS allele
– Lack of written consent
– Minors (not 18 years old) or under guardianship
– Diseases : HIV, Hepatitis B, Hepatitis C or HTLV (Human T Leukemia Virus).